TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Craneware ( (GB:CRW) ) just unveiled an announcement.
Craneware plc announced the grant of conditional share awards under its Long Term Incentive Plan (2022) to key executives, including the CEO, CFO, CPO, and CLO. These awards are contingent on performance conditions related to shareholder return and earnings growth over a five-year period, with a two-year holding period post-vesting, reflecting the company’s commitment to aligning executive incentives with long-term shareholder value.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £2492.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Spark’s Take on GB:CRW Stock
According to Spark, TipRanks’ AI Analyst, GB:CRW is a Outperform.
Craneware’s overall stock score reflects its strong financial performance and positive corporate events, which are somewhat offset by a high valuation and mixed technical indicators. The company’s strategic initiatives and solid financial health position it well, but the high P/E ratio may concern value-focused investors.
To see Spark’s full report on GB:CRW stock, click here.
More about Craneware
Craneware plc is a leader in healthcare financial performance solutions, focusing on enhancing the financial and operational performance of healthcare organizations.
Average Trading Volume: 96,563
Technical Sentiment Signal: Strong Buy
Current Market Cap: £815.9M
Find detailed analytics on CRW stock on TipRanks’ Stock Analysis page.